Aptevo Therapeutics Inc.

Aptevo Therapeutics Inc. financial statements

Aptevo Therapeutics Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

FY2025

RevenueUSD 0EODHD
Net income−USD 25.97M10-K
Cash and equivalentsUSD 21.62M10-Q
Total debtUSD 4.63MEODHD

Aptevo Therapeutics Inc. financials on 6ix · Aptevo Therapeutics Inc. on 6ix